Clinical Trial Update: A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety, immunogenicity, and efficacy of a trivalent rotavirus P2-VP8 subunit vaccine in healthy infants in Africa and India; current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis
• Rotavirus Infection in Children

Drugs mentioned

• P2-VP8 subunit vaccine (trivalent rotavirus vaccine)

Snippet

Sponsor: PATH | Conditions: Rotavirus Infection of Children | Phase 3 | Status: UNKNOWN